Recent advances in the diagnosis and the treatment of primary CNS lymphoma

A Rachdi, H Hernandez-Tost, D Herzi… - Revue …, 2023 - Elsevier
This review focuses on the recent progress in the management of primary central nervous
system lymphoma (PCNSL). Multiomic analyses allowed to better understand the …

Primary CNS lymphoma: update on molecular pathogenesis and therapy

SS Mo, J Cleveland, JL Rubenstein - Leukemia & Lymphoma, 2023 - Taylor & Francis
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive form of extra-
nodal non-Hodgkin lymphoma that as a brain tumor poses a unique set of challenges in …

Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma

Z Lin, J Ma, Y Ma, Q Li, H Kang, M Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Primary central nervous system lymphoma (PCNSL) is an aggressive
extranodal non-Hodgkin lymphoma with a poor prognosis. We aimed to evaluate the …

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed …

J Wu, W Liu, Y Cao, Y Yang, Z Shang, M Zhou… - Cancer Immunology …, 2024 - Springer
Background Several reports have indicated that chimeric antigen receptor (CAR) T-cell
therapy following autologous hematopoietic stem cell transplantation (ASCT) is a promising …

Conditional survival of elderly primary central nervous system lymphoma

H Qian, Z Yang, L Cai, H Chen - Journal of Cancer Research and Clinical …, 2023 - Springer
Background Recent studies have reported that overall survival of elderly patients with
primary central nervous system lymphoma (PCNSL), who have the highest incidence of this …

Decision tree model for predicting the overall survival of patients with diffused large b-cell lymphoma in the central nervous system

H Huang, ZH Yang, ZW Gu, M Luo, L Xu - World Neurosurgery, 2022 - Elsevier
Objective To identify the significant predictors of overall survival for patients living with
diffused large B-cell lymphoma (DLBCL) in the central nervous system and establish a novel …

Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical …

D Li, S Li, Z Xia, J Cao, J Zhang, B Chen, X Zhang… - EPMA Journal, 2022 - Springer
Background/aims Predicting the clinical outcomes of primary diffuse large B-cell lymphoma
of the central nervous system (PCNS-DLBCL) to methotrexate-based combination …

Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies

I Hernández-Verdin, A Morales-Martínez… - Current Opinion in …, 2022 - journals.lww.com
Primary central nervous system lymphoma: advances in its pat... : Current Opinion in Neurology
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers …

Advances in Primary Central Nervous System Lymphoma

KE Therkelsen, A Omuro - Current Neurology and Neuroscience Reports, 2025 - Springer
Abstract Purpose of Review Optimal initial management can have a significant impact in
long-term outcome in primary CNS lymphoma. This article reviews recent advances and the …

Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis

L He, J Zhang, X Chen, R Wei - BMC ophthalmology, 2022 - Springer
Background Primary intraocular lymphoma (PIOL) is a rare malignancy with a poor
prognosis, but its optimal therapy remains unclear. Herein, we aimed to analyze the …